4 1 four.txt 4 FORM 4 [ ] Check box if no ------------------------------------ longer subject to OMB APPROVAL Section 16. Form 4 or ------------------------------------ Form 5 obligations may OMB Number 3235-0287 continue. See Instruction 1(b) Expires: December 31, 2001 Estimated average burden hours per response .............0.5 ------------------------------------ U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 ------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* Gluskin Anna E. -------------------------------------------------------------------- (Last) (First) (Middle) 33 Harbour Square, Suite 202 -------------------------------------------------------------------- (Street) Toronto, Ontario (Canada) M5J 2G2 -------------------------------------------------------------------- (City) (State) (Zip) ------------------------------------------------------------------------------- 2. Issuer Name and Ticker or Trading Symbol Generex Biotechnology Corporation (GNBT) ------------------------------------------------------------------------------- 3. IRS or Social Security Number of Reporting Person (Voluntary) ------------------------------------------------------------------------------- 4. Statement for Month/Year | 5. If Amendment, Date of | Original (Month/Year) January/2002 | ------------------------------------------------------------------------------- 6. Relationship of Reporting Person to Issuer (Check all applicable) [ X ] Director [ ] 10% Owner [ X ] Officer [ ] Other (specify below) (give title below) President and Chief Executive Officer ------------------------------------------------------------------------------- 7. Individual or Joint/Group Reporting (Check Applicable Line) X Form Filed by One Reporting Person --- Form Filed by More than One Reporting Person --- ------------------------------------------------------------------------------- ------------------------------------------------------------------------------- TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned -------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Security | 2. Transaction Date | 3. Transaction Code | 4. Security Acquired (A) or Disposed (Instr. 3) | (Month/Day/Year) | (Instr. 8) | of (D) (Instr. 3, 4 and 5) | | | ----------------------------------------------------------------------------------------------------------------------------------- | | | Amount | (A) or| Price | | | | (D) | ----------------------------------------------------------------------------------------------------------------------------------- Common Stock | 1/22/02 | P | 1,000 | (A) | $6.39 ----------------------------------------------------------------------------------------------------------------------------------- Common Stock | 1/22/02 | P | 1,000 | (A) | $6.50 ----------------------------------------------------------------------------------------------------------------------------------- Common Stock | 1/25/02 | P | 1,000 | (A) | $6.54 ----------------------------------------------------------------------------------------------------------------------------------- Common Stock | | | | | ----------------------------------------------------------------------------------------------------------------------------------- | | | | | ===================================================================================================================================
--------------------------------------------------------------------------------------------------------------------------------- 1. Title of Security | 5. Amount of Securities | 6. Ownership Form: | 7. Nature of Indirect Beneficial (Instr. 3) | Beneficially Owned at | Direct (D) or | Ownership (Instr. 4) | End of Month | Indirect (I) | | (Instr. 3 & 4) | (Instr. 4) | --------------------------------------------------------------------------------------------------------------------------------- Common Stock | | | --------------------------------------------------------------------------------------------------------------------------------- Common Stock | | | --------------------------------------------------------------------------------------------------------------------------------- Common Stock | 3,000 | D | --------------------------------------------------------------------------------------------------------------------------------- Common Stock | 1,188,127 | I | by GHI, Inc. --------------------------------------------------------------------------------------------------------------------------------- | | | =================================================================================================================================
*If the form is filed by more than one reporting person, see Instruction 4(b)(v). (over) SEC 1474 (3-91) FORM 4 (continued) TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative Security | 2. Conversion or | 3. Transaction Date | 4. Transaction | 5. Number of Derivative (Instr. 3) | Exercise Price of | (Month/Day/Year) | Code | Securities Acquired | Derivative Security | | (Instr. 8) | (A) or Disposed of | | | | (D) (Instr. 3, 4 and 5) ----------------------------------------------------------------------------------------------------------------------------------- | (A) | (D) ----------------------------------------------------------------------------------------------------------------------------------- Option to buy | $5.00 | | | | ----------------------------------------------------------------------------------------------------------------------------------- Option to buy | $7.5625 | | | | ----------------------------------------------------------------------------------------------------------------------------------- | | | | | ===================================================================================================================================
----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative Security | 6. Date Exercisable and | 7. Title and Amount of Underlying | 8. Price of Derivative (Instr. 3) | Expiration Date | Securities (Instr. 3 and 4) | Security (Instr. 5) | (Month/Day/Year) | | | | | ----------------------------------------------------------------------------------------------------------------------------------- | Date | Expiration | Title | Amount or Number | | Exercisable | Date | | of Shares | | | | | | | | | | | ----------------------------------------------------------------------------------------------------------------------------------- Option to buy | 1/3/00 | 1/3/05 | Common Stock | 100,000 | ----------------------------------------------------------------------------------------------------------------------------------- Option to buy | 7/31/00 | 7/31/05 | Common Stock | 200,000 | ----------------------------------------------------------------------------------------------------------------------------------- | | | | | ===================================================================================================================================
----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative Security | 9. Number Derivative | 10. Ownership of Derivative | 11. Nature of Indirect (Instr. 3) | Securities Beneficially | Security: Direct (D) or | Beneficial Ownership | Owned at End of Month | Indirect (I) (Instr. 4) | (Instr. 4) | (Instr. 4) | | ----------------------------------------------------------------------------------------------------------------------------------- Option to buy | | | ----------------------------------------------------------------------------------------------------------------------------------- Option to buy | 300,000 | D | ----------------------------------------------------------------------------------------------------------------------------------- | | | ===================================================================================================================================
Explanation of Responses: /s/ Anna E. Gluskin February 8, 2002 ------------------------------------ ------------------- **Signature of Reporting Person Date Anna E. Gluskin ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).